<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">STAR Protoc</journal-id><journal-id journal-id-type="iso-abbrev">STAR Protoc</journal-id><journal-title-group><journal-title>STAR Protocols</journal-title></journal-title-group><issn pub-type="epub">2666-1667</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9440482</article-id><article-id pub-id-type="pii">S2666-1667(22)00529-9</article-id><article-id pub-id-type="doi">10.1016/j.xpro.2022.101649</article-id><article-id pub-id-type="publisher-id">101649</article-id><article-categories><subj-group subj-group-type="heading"><subject>Protocol</subject></subj-group></article-categories><title-group><article-title>Protocol for the isolation of CD8+ tumor-infiltrating lymphocytes from human tumors and their characterization by single-cell immune profiling and multiome</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Anadon</surname><given-names>Carmen M.</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn1" ref-type="fn">4</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Zhang</surname><given-names>Chaomei</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Wang</surname><given-names>Xuefeng</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Cen</surname><given-names>Ling</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author" id="au5"><name><surname>Conejo-Garcia</surname><given-names>Jose R.</given-names></name><email>jose.conejo-garcia@moffitt.org</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author" id="au6"><name><surname>Yu</surname><given-names>Xiaoqing</given-names></name><email>xiaoqing.yu@moffitt.org</email><xref rid="aff3" ref-type="aff">3</xref><xref rid="fn2" ref-type="fn">5</xref><xref rid="cor2" ref-type="corresp">&#x02217;&#x02217;</xref></contrib><aff id="aff1"><label>1</label>Department of Immunology, H. Lee Moffitt Cancer Center &#x00026; Research Institute, Tampa, FL 33614, USA</aff><aff id="aff2"><label>2</label>Molecular Genomics Core Facility, H. Lee Moffitt Cancer Center &#x00026; Research Institute, Tampa, FL 33614, USA</aff><aff id="aff3"><label>3</label>Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center &#x00026; Research Institute, Tampa, FL 33614, USA</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author <email>jose.conejo-garcia@moffitt.org</email></corresp><corresp id="cor2"><label>&#x02217;&#x02217;</label>Corresponding author <email>xiaoqing.yu@moffitt.org</email></corresp><fn id="fn1"><label>4</label><p id="ntpara0010">Technical contact: <ext-link ext-link-type="uri" xlink:href="mailto:carmen.anadon@moffitt.org" id="intref0010">carmen.anadon@moffitt.org</ext-link></p></fn><fn id="fn2"><label>5</label><p id="ntpara0015">Lead contact</p></fn></author-notes><pub-date pub-type="pmc-release"><day>26</day><month>8</month><year>2022</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><day>16</day><month>9</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>26</day><month>8</month><year>2022</year></pub-date><volume>3</volume><issue>3</issue><elocation-id>101649</elocation-id><permissions><copyright-statement>&#x000a9; 2022 The Author(s)</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><title>Summary</title><p>Understanding the heterogenicity of tumor-infiltraing lymphocyte (TIL) populations and the immunobiology in human cancer is a key to establish efficient immunotherapies. Here, we have established a protocol for the characterization of CD8<sup>+</sup> TILs in tumors by single-cell RNA-seq paired to VDJ profiling and chromatin structure including dissociation of tumor biopsies. We have also provided guidance for subsequent fluorescence-activated cell sorting (FACS), single-cell encapsulation, bioinformatics analysis, and troubleshooting.</p><p>For complete details on the use and execution of this protocol, please refer to <xref rid="bib2" ref-type="bibr">Anadon et&#x000a0;al. (2022)</xref>.</p></abstract><abstract abstract-type="graphical" id="abs0015"><title>Graphical abstract</title><fig id="undfig1" position="anchor"><graphic xlink:href="fx1"/></fig></abstract><abstract abstract-type="author-highlights" id="abs0020"><title>Highlights</title><p><list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#x02022;</label><p id="p0010">Single-cell suspension preparation and TILs sorting from frozen human ovarian tumors</p></list-item><list-item id="u0015"><label>&#x02022;</label><p id="p0015">Single-cell isolation, library preparation, and quality control for scRNA-seq + VDJ</p></list-item><list-item id="u0020"><label>&#x02022;</label><p id="p0020">Single nucleus isolation, library preparation, and quality control for 10&#x000d7; Multiome</p></list-item><list-item id="u0025"><label>&#x02022;</label><p id="p0025">scRNA-seq + VD and Multiome data integration and TIL trajectory identification</p></list-item></list></p></abstract><abstract abstract-type="editor-highlights" id="abs0025"><p>Publisher&#x02019;s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.</p></abstract><abstract abstract-type="teaser" id="abs0030"><p>Understanding the heterogenicity of tumor-infiltraing lymphocyte (TIL) populations and the immunobiology in human cancer is a key to establish efficient immunotherapies. Here, we have established a protocol for the characterization of CD8<sup>+</sup> TILs in tumors by single-cell RNA-seq paired to VDJ profiling and chromatin structure including dissociation of tumor biopsies. We have also provided guidance for subsequent fluorescence-activated cell sorting (FACS), single-cell encapsulation, bioinformatics analysis, and troubleshooting.</p></abstract><kwd-group id="kwrds0010"><title>Subject areas</title><kwd>Bioinformatics</kwd><kwd>Sequence analysis</kwd><kwd>Cell isolation</kwd><kwd>Single cell</kwd><kwd>Flow cytometry/Mass cytometry</kwd><kwd>Clinical protocol</kwd><kwd>Sequencing</kwd><kwd>RNAseq</kwd><kwd>Gene expression</kwd></kwd-group></article-meta></front><body><sec id="sec1"><title>Before you begin</title><p id="p0035">The protocol below describes the specific steps for characterization of CD8<sup>+</sup> TILs using human ovarian tumor samples. However, we have also used this protocol with other human tumors such as lung cancer or. cutaneous T-cell lymphoma. For lung cancer, tumor processing was done in the same way and for cutaneous T-cell lymphina we sorted malignat cells directly from peripheral blood.</p><sec id="sec1.1"><title>Institutional permission</title><p id="p0040">This study has received institutional regulatory approval. Human high grade serous ovarian carcinoma (HGSOC) tissues were procured under protocols approved by the Committee for the Protection of Human Subjects at Dartmouth&#x02013;Hitchcock Medical Center (no. 17702) or under a protocol approved by the H. Lee Moffitt Cancer Center (MCC no. 18974). Informed consent was obtained from all them.</p><p id="p0045">Researchers should be aware of the legal requirements for the access to human specimens applicable at their institution.</p></sec><sec id="sec1.2"><title>Preparation for tumor processing and generating single-cell suspension from tumors</title><p id="p0050">
<disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: &#x0223c;30&#x000a0;min</bold></p></disp-quote>
<list list-type="simple" id="olist0010"><list-item id="o0010"><label>1.</label><p id="p0055">Prepare fresh R10 medium as described in the <xref rid="sec2" ref-type="sec">materials and equipment</xref> section.</p></list-item><list-item id="o0015"><label>2.</label><p id="p0060">Prepare RBC lysis buffer.</p></list-item><list-item id="o0020"><label>3.</label><p id="p0065">Pre-scour dish with two scalpels to help the dissociation.</p></list-item><list-item id="o0025"><label>4.</label><p id="p0070">Prepare freezing medium.</p></list-item><list-item id="o0030"><label>5.</label><p id="p0075">Be sure you have cryofreezing chambers (Mr. Frosty) at room temperature ready to use.</p></list-item></list>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> Cell viability decrease with time, therefore try to process the sample quickly, centrifuge at 4&#x000b0;C and keep the sample on ice. Always keep tumor sample wet with a few mL of R10 media.</p></disp-quote>
</p></sec><sec id="sec1.3"><title>Preparation before processing the sample for FACs sorting and encapsulation</title><p id="p0080">
<disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: 30&#x02013;60&#x000a0;min</bold></p></disp-quote>
<list list-type="simple" id="olist0015"><list-item id="o0035"><label>6.</label><p id="p0085">Be sure that you have EasySep&#x02122; Dead Cell Removal (Annexin V) Kit - STEMCELL.</p></list-item><list-item id="o0040"><label>7.</label><p id="p0090">Prepare fresh dead cell removal buffer.</p></list-item><list-item id="o0045"><label>8.</label><p id="p0095">Prepare fresh sorting buffer and filtered FBS (0.2&#x000a0;&#x003bc;m) for recollection.</p></list-item><list-item id="o0050"><label>9.</label><p id="p0100">Prepare fresh single cell resuspension solution.</p></list-item></list>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> Filter the single cell resuspension solution (0.2&#x000a0;&#x003bc;m) to avoid particles that can affect to the encapsulation process.</p></disp-quote>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> Cell viability is the measurement of propotion of live and healthy cells within the single cell resuspection solucion. Cell viability is critical for the encapsulation to work and get good quality of RNA and DNA for post sequencing. The viability suggested from 10&#x000d7; Genomix is &#x0003e;85% but viability &#x0003e;70% is acceptable. We highly recommended to measure the viability again after sorting.</p></disp-quote>
</p></sec><sec id="sec1.4"><title>Preparation before encapsulation</title><p id="p0105">
<disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: &#x0223c;1 h</bold></p></disp-quote>
<list list-type="simple" id="olist0020"><list-item id="o0055"><label>10.</label><p id="p0110">Prepare diluted nuclear buffer.</p></list-item><list-item id="o0060"><label>11.</label><p id="p0115">Prepare wash buffer.</p></list-item><list-item id="o0065"><label>12.</label><p id="p0120">Prepare lysis buffer.</p></list-item><list-item id="o0070"><label>13.</label><p id="p0125">Prepare transposition buffer.</p></list-item><list-item id="o0075"><label>14.</label><p id="p0130">Prepare GEM master mix.</p></list-item></list>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> All buffers and mix must be made fresh.</p></disp-quote>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> Cells may have varied cells and be sure that enough wash buffer is made ahead. Cell lysis time is fixed once the optimized lysis is determined. However, if the cell number is between 100,000&#x02013;1,000,000, the step 2 in the protocol of nuclei isolation for single cell multiome ATAC&#x000a0;+ gene expression sequencing is followed. Otherwise, the steps in Appendix should be followed instead in order to minimize the cell loss.</p></disp-quote>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> The cell lysis time may need be optimized and the optimized lysis should be followed for all the samples.</p></disp-quote>
</p></sec></sec><sec id="sec8"><title>Key resources table</title><p id="p0865">
<table-wrap position="float" id="undtbl12"><table frame="hsides" rules="groups"><thead><tr><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr><td colspan="3"><bold>Antibodies</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Mouse anti-human CD45 (Working dilution: 5:200)</td><td>BD Biosciences</td><td>BD Biosciences Cat# 563716, Clone H130, RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_2716864" id="intref0080">AB_2716864</ext-link></td></tr><tr><td>Mouse anti-human CD3 (Working dilution: 5:200)</td><td>Tonbo Biosciences</td><td>Tonbo Biosciences Cat# 65-0037, Clone OKT3, RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_2621873" id="intref0085">AB_2621873</ext-link></td></tr><tr><td>Mouse anti-human CD8 (Working dilution: 5:200)</td><td>BD Biosciences</td><td>BD Biosciences Cat# 564628, Clone SK1, RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_2744464" id="intref0090">AB_2744464</ext-link></td></tr><tr><td>Mouse anti-human CD4 (Working dilution: 5:200)</td><td>BD Biosciences</td><td>BD Biosciences Cat# 563552, Clone SK3, RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_2738275" id="intref0095">AB_2738275</ext-link></td></tr><tr><td>Mouse anti-human CD69 (Working dilution: 5:200)</td><td>BioLegend</td><td>BioLegend Cat# 310942, Clone FN50, RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_2564277" id="intref0100">AB_2564277</ext-link></td></tr><tr><td>Mouse anti-human CD103 (Integrin alpha E) (Working dilution: 5:200)</td><td>BioLegend</td><td>BioLegend Cat# 350205, Clone Ber-ACT8, RRID: <ext-link ext-link-type="uri" xlink:href="nif-antibody:AB_10642026" id="intref0105">AB_10642026</ext-link></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Biological samples</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Human ovarian carcinoma tissues</td><td>H. Lee Moffitt Cancer Center</td><td>N/A</td></tr><tr><td>Human ovarian carcinoma tissues</td><td>Darmouth Hitchcock Medical Center</td><td>N/A</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Chemicals, peptides, and recombinant proteins</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>RPMI 1640 Medium</td><td>Gibco</td><td>Cat# 11875093</td></tr><tr><td>Penicillin/Streptomycin</td><td>Lonza</td><td>Cat# 17602E</td></tr><tr><td>L-glutamine</td><td>Genesee Scientific</td><td>Cat# 25509</td></tr><tr><td>Sodium pyruvate</td><td>Thermo Fisher Scientific</td><td>Cat# 11360070</td></tr><tr><td>Dulbecco&#x02019;s Phosphate Buffered Saline 1&#x000d7;</td><td>VWR Life Science</td><td>Cat# 0201190500</td></tr><tr><td>Dulbecco&#x02019;s Phosphate Buffered Saline (DPBS), 1&#x000d7;, with calcium, magnesium</td><td>Thermo Fisher Scientific</td><td>Cat# 16777-257</td></tr><tr><td>Gamma-Globulins from Human Blood</td><td>Sigma</td><td>Cat# G4386</td></tr><tr><td>Human TruStain FcX&#x02122; (Fc Receptor Blocking Solution)</td><td>BioLegend</td><td>Cat# 422301</td></tr><tr><td>DAPI</td><td>Sigma</td><td>Cat# 8417</td></tr><tr><td>EDTA 0.5&#x000a0;M pH8.0</td><td>Invitrogen</td><td>Cat# 15575038</td></tr><tr><td>NH<sub>4</sub>Cl</td><td>Sigma</td><td>Cat# A9434</td></tr><tr><td>KHCO<sub>3</sub></td><td>Fisher Chemical</td><td>Cat# 298146</td></tr><tr><td>DMSO</td><td>Fisher Chemical</td><td>Cat# D1284</td></tr><tr><td>HEPES (1 M)</td><td>Gibco</td><td>Cat# 15630080</td></tr><tr><td>Fetal Bovine Serum</td><td>Biowest</td><td>Cat# S1620</td></tr><tr><td>Ultrapure BSA</td><td>Invitrogen</td><td>Cat# AM2616</td></tr><tr><td>Nuclei Buffer (20&#x000d7;)</td><td>10&#x000d7; Genomics</td><td>Cat# 2000207</td></tr><tr><td>DTT</td><td>Sigma-Aldrich</td><td>Cat# 646563</td></tr><tr><td>RNase inhibitor</td><td>Sigma-Aldrich</td><td>Cat# 333502001</td></tr><tr><td>Nuclease-free Water</td><td>Invitrogen</td><td>Cat# AM9937</td></tr><tr><td>Tris-HCl (pH 7.4)</td><td>Sigma-Aldrich</td><td>Cat# T2194</td></tr><tr><td>NaCl</td><td>Sigma-Aldrich</td><td>Cat# 59222C</td></tr><tr><td>MgCl2</td><td>Sigma-Aldrich</td><td>Cat# M1028</td></tr><tr><td>BSA</td><td>Miltenyi Biotec</td><td>Cat# 130-091-376</td></tr><tr><td>Tween-20</td><td>Bio-Rad</td><td>Cat# 1662404</td></tr><tr><td>Nonidet P40 Substitute</td><td>Sigma-Aldrich</td><td>Cat# 74385</td></tr><tr><td>Digitonin</td><td>Thermo Fisher Scientific</td><td>Cat# BN2006</td></tr><tr><td>TAC Buffer B</td><td>10&#x000d7; Genomics</td><td>Cat# 2000193</td></tr><tr><td>TAC Enzyme B</td><td>10&#x000d7; Genomics</td><td>Cat# 2000265</td></tr><tr><td>Barcoding Reagent Mix</td><td>10&#x000d7; Genomics</td><td>Cat# 2000267</td></tr><tr><td>Template Switch Oligo</td><td>10&#x000d7; Genomics</td><td>Cat# 3000228</td></tr><tr><td>Reducing Agent B</td><td>10&#x000d7; Genomics</td><td>Cat# 2000087</td></tr><tr><td>Barcoding Enzyme Mix</td><td>10&#x000d7; Genomics</td><td>Cat# 2000266</td></tr><tr><td>Trypan Blue Solution, 0.4%</td><td>Thermo Fisher Scientific</td><td>Cat# 15250061</td></tr><tr><td>ViaStain AO/PI Staining Solution</td><td>Nexcelom Bioscience</td><td>Cat# CS2-0106-5</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Critical commercial assays</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>EasySep&#x02122; Dead Cell Removal (Annexin V) Kit</td><td>STEMCELL Technologies</td><td>Cat# 17899</td></tr><tr><td>Chromium&#x02122; Next GEM Single Cell 5&#x02032; Library and Gel Bead Kit v1.1</td><td>10&#x000d7; Genomics</td><td>Cat#1000165</td></tr><tr><td>Chromium&#x02122; Single Cell V(D)J Enrichment Kit, Human T Cell</td><td>10&#x000d7; Genomics</td><td>Cat#1000005</td></tr><tr><td>Chromium&#x02122; Single Cell 5&#x02032; Library Construction Kit</td><td>10&#x000d7; Genomics</td><td>Cat# 1000020</td></tr><tr><td>Chromium&#x02122; Next GEM Chip G Single Cell Kit</td><td>10&#x000d7; Genomics</td><td>Cat# 1000127</td></tr><tr><td>Chromium Next GEM Single Cell Multiome ATAC&#x000a0;+ Gene Expression Reagent Bundle</td><td>10&#x000d7; Genomics</td><td>Cat# 1000285</td></tr><tr><td>Chromium Next GEM Chip J Single Cell Kit</td><td>10&#x000d7; Genomics</td><td>Cat# 1000230</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Deposited data</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td><bold>Custom</bold> Source Code</td><td>This paper: GitHub folder: xxy39/TRM_OV_sc</td><td>GitHub: <ext-link ext-link-type="uri" xlink:href="https://github.com/xxy39/TRM_OV_sc" id="intref0110">https://github.com/xxy39/TRM_OV_sc</ext-link></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Software and algorithms</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>FlowJo v10.7.2</td><td>FlowJo LLC</td><td>N/A</td></tr><tr><td>CellRanger v5.0</td><td>10&#x000d7; Genomics</td><td><ext-link ext-link-type="uri" xlink:href="http://10xgenomics.com/" id="intref0115">http://10xgenomics.com/</ext-link></td></tr><tr><td>Seurat v4.0 (R package)</td><td><xref rid="bib6" ref-type="bibr">Stuart et&#x000a0;al. (2019)</xref></td><td><ext-link ext-link-type="uri" xlink:href="https://satijalab.org/seurat/" id="intref0120">https://satijalab.org/seurat/</ext-link></td></tr><tr><td>AUCell (R package)</td><td><xref rid="bib1" ref-type="bibr">Aibar et&#x000a0;al. (2017)</xref></td><td><ext-link ext-link-type="uri" xlink:href="https://github.com/aertslab/AUCell" id="intref7610">https://github.com/aertslab/AUCell</ext-link></td></tr><tr><td>Cell Ranger VDJ v3.0</td><td>10&#x000d7; Genomics</td><td><ext-link ext-link-type="uri" xlink:href="http://10xgenomics.com/" id="intref0130">http://10xgenomics.com/</ext-link></td></tr><tr><td>Fossil (R package)</td><td><xref rid="bib8" ref-type="bibr">Vavrek (2011)</xref></td><td><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/fossil/index.html" id="intref0135">https://cran.r-project.org/web/packages/fossil/index.html</ext-link></td></tr><tr><td>Signac v1.3.0 (R package)</td><td><xref rid="bib7" ref-type="bibr">Stuart et al. (2021)</xref></td><td><ext-link ext-link-type="uri" xlink:href="https://docs.signac.io/projects/core/en/v1.3.0/" id="intref0140">https://docs.signac.io/projects/core/en/v1.3.0/</ext-link></td></tr><tr><td>harmony (R package)</td><td><xref rid="bib3" ref-type="bibr">Korsunsky et&#x000a0;al. (2019)</xref></td><td><ext-link ext-link-type="uri" xlink:href="https://github.com/immunogenomics/harmony" id="intref0145">https://github.com/immunogenomics/harmony</ext-link></td></tr><tr><td>JASPAR2020 v0.99 (R package)</td><td>JASPAR</td><td><ext-link ext-link-type="uri" xlink:href="http://bioconductor.org/packages/release/data/annotation/html/JASPAR2020.html" id="intref0150">http://bioconductor.org/packages/release/data/annotation/html/JASPAR2020.html</ext-link></td></tr><tr><td>TFBStools v1.31.2 (R package)</td><td><xref rid="bib9" ref-type="bibr">Tan and Lenhard (2016)</xref></td><td><ext-link ext-link-type="uri" xlink:href="https://github.com/ge11232002/TFBSTools" id="intref0155">https://github.com/ge11232002/TFBSTools</ext-link></td></tr><tr><td>FastIntegration v1.0.0</td><td><xref rid="bib4" ref-type="bibr">Li et&#x000a0;al. (2022)</xref></td><td><ext-link ext-link-type="uri" xlink:href="https://github.com/JinmiaoChenLab/FastIntegration" id="intref0160">https://github.com/JinmiaoChenLab/FastIntegration</ext-link></td></tr><tr><td>TRM_OV_sc</td><td>Current Manuscripts</td><td><ext-link ext-link-type="uri" xlink:href="https://github.com/xxy39/TRM_OV_sc" id="intref0165">https://github.com/xxy39/TRM_OV_sc</ext-link><ext-link ext-link-type="doi" xlink:href="10.5281/zendo.6828033" id="intref0170">https://doi.org/10.5281/zendo.6828033</ext-link></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Other</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>BD FACSAria&#x02122; III Cell Sorter</td><td>BD Biosciences</td><td>N/A</td></tr><tr><td>Cellometer K2 instrument</td><td>VWR</td><td>Cat# NEXCMK2</td></tr><tr><td>Advanced Cell Strainers, 100&#x000a0;&#x003bc;m</td><td>Genesee Scientific</td><td>Cat # 25-375</td></tr><tr><td>Advanced Cell Strainers, 70&#x000a0;&#x003bc;m</td><td>Genesee Scientific</td><td>Cat # 25-376</td></tr><tr><td>Sartorius Minisart NMLSyringe Filters,0.45&#x000a0;&#x003bc;m, Yellow</td><td>Fisher Scientific</td><td>Cat# 14555308</td></tr><tr><td>Sartorius Minisart NMLSyringe Filters,0.2&#x000a0;&#x003bc;m, Blue</td><td>Fisher Scientific</td><td>Cat# 14555306</td></tr><tr><td>Fisherbrand&#x02122; Petri Dishes with Clear Lid</td><td>Fisher Scientific</td><td>Cat# FB0875712</td></tr><tr><td>CellPro&#x02122; 15&#x000a0;mL Conical Tubes, Centrifuge Tubes</td><td>Alkali Scienti</td><td>Cat# CN5601</td></tr><tr><td>CellPro&#x02122; 50&#x000a0;mL Conical Tubes</td><td>Alkali Scientific</td><td>Cat# CN5603</td></tr><tr><td>Disposable Serological Pipets 5&#x000a0;mL</td><td>VWR</td><td>Cat# 89130-896</td></tr><tr><td>Disposable Serological Pipets 10&#x000a0;mL</td><td>VWR</td><td>Cat# 89130-898</td></tr><tr><td>Disposable Serological Pipets 25&#x000a0;mL</td><td>VWR</td><td>Cat# 89130-900</td></tr><tr><td>Corning&#x02122; Falcon&#x02122; Round-Bottom Polystyrene Test Tubes</td><td>Fisher Scientific</td><td>Cat# 14-959-2A</td></tr><tr><td>Thermo Scientific&#x02122; Mr. Frosty&#x02122; Freezing Container</td><td>Fisher Scientific</td><td>Cat# 15-350-50</td></tr><tr><td>Neubauer Chamber (Hausser Scientific&#x02122; Bright-Line&#x02122; Counting Chamber)</td><td>Fisher Scientific</td><td>Cat# 02-671-51B</td></tr></tbody></table></table-wrap>
</p></sec><sec id="sec2"><title>Materials and equipment</title><p id="p0135">
<table-wrap position="float" id="undtbl1"><caption><p>R10</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Reagent</th><th>Final concentration</th><th>Amount</th></tr></thead><tbody><tr><td>RPMI-1640</td><td>N/A</td><td>440&#x000a0;mL</td></tr><tr><td>FBS</td><td>10%</td><td>50&#x000a0;mL</td></tr><tr><td>L-Glutamine</td><td>2&#x000a0;mM</td><td>5&#x000a0;mL</td></tr><tr><td>Penicillin/Streptomycin</td><td>100&#x000a0;&#x003bc;g/mL</td><td>5&#x000a0;mL</td></tr><tr><td>Sodium Pyruvate</td><td>0.5&#x000a0;mM</td><td>2.5&#x000a0;mL</td></tr><tr><td><bold>Total</bold></td><td><bold>N/A</bold></td><td><bold>500&#x000a0;mL</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Storage at 4&#x000b0;C. The medium can be stored for a month.</p></fn></table-wrap-foot></table-wrap>
<table-wrap position="float" id="undtbl2"><caption><p>RBC Lysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Reagent</th><th>Final concentration</th><th>Amount</th></tr></thead><tbody><tr><td>NH<sub>4</sub>Cl</td><td>N/A</td><td>4.01 g</td></tr><tr><td>KHCO<sub>3</sub></td><td>N/A</td><td>0.5 g</td></tr><tr><td>EDTA (0.5 M)</td><td>70&#x000a0;&#x003bc;M</td><td>70&#x000a0;&#x003bc;L</td></tr><tr><td>dH2O</td><td>N/A</td><td>500&#x000a0;mL</td></tr><tr><td><bold>Total</bold></td><td><bold>N/A</bold></td><td><bold>500&#x000a0;mL</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Storage at 4&#x000b0;C. It can be at this temperature for a week.</p></fn></table-wrap-foot></table-wrap>
<table-wrap position="float" id="undtbl3"><caption><p>Freezing medium</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Reagent</th><th>Final concentration</th><th>Amount</th></tr></thead><tbody><tr><td>FBS</td><td>N/A</td><td>450&#x000a0;mL</td></tr><tr><td>DMSO</td><td>10%</td><td>50&#x000a0;mL</td></tr><tr><td><bold>Total</bold></td><td><bold>N/A</bold></td><td><bold>500&#x000a0;mL</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Storage at 4&#x000b0;C. The medium can be stored for a month.</p></fn></table-wrap-foot></table-wrap>
<table-wrap position="float" id="undtbl4"><caption><p>Dead cell removal buffer</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Reagent</th><th>Final concentration</th><th>Amount</th></tr></thead><tbody><tr><td>PBS with Calcium</td><td>1&#x000a0;mM</td><td>490&#x000a0;mL</td></tr><tr><td>FBS</td><td>2%</td><td>10&#x000a0;mL</td></tr><tr><td><bold>Total</bold></td><td><bold>N/A</bold></td><td><bold>500&#x000a0;mL</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Storage at 4&#x000b0;C. The medium can be stored for a month.</p></fn></table-wrap-foot></table-wrap>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> Ca<sup>++</sup> is required for product performance.</p></disp-quote>
<table-wrap position="float" id="undtbl5"><caption><p>Sorting buffer</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Reagent</th><th>Final concentration</th><th>Amount</th></tr></thead><tbody><tr><td>PBS (100 <bold>&#x003bc;</bold>M)</td><td>N/A</td><td>477.5&#x000a0;mL</td></tr><tr><td>FBS (10%)</td><td>20%</td><td>10&#x000a0;mL</td></tr><tr><td>HEPES (1 M)</td><td>25&#x000a0;mM</td><td>12.5&#x000a0;mL</td></tr><tr><td><bold>Total</bold></td><td><bold>N/A</bold></td><td><bold>500&#x000a0;mL</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Storage at 4&#x000b0;C. The medium can be stored for a month.</p></fn></table-wrap-foot></table-wrap>
<table-wrap position="float" id="undtbl6"><caption><p>Single-cell resuspension solution</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Reagent</th><th>Final concentration</th><th>Amount</th></tr></thead><tbody><tr><td>PBS</td><td>N/A</td><td>49.6&#x000a0;mL</td></tr><tr><td>BSA (50&#x000a0;mg/mL)</td><td>0.04%</td><td>400&#x000a0;&#x003bc;L</td></tr><tr><td><bold>Total</bold></td><td><bold>N/A</bold></td><td><bold>50&#x000a0;mL</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Storage at 4&#x000b0;C. The medium can be stored for 1&#x000a0;week.</p></fn></table-wrap-foot></table-wrap>
<table-wrap position="float" id="undtbl7"><caption><p>Diluted nuclei buffer</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Reagent</th><th>Final concentration</th><th>Amount</th></tr></thead><tbody><tr><td>Nuclei Buffer (20&#x000d7;)</td><td>1&#x000d7;</td><td>50&#x000a0;&#x003bc;L</td></tr><tr><td>DTT (1,000&#x000a0;mM)</td><td>1&#x000a0;mM</td><td>1&#x000a0;&#x003bc;L</td></tr><tr><td>RNase inhibitor (40&#x000a0;U/ &#x003bc;L)</td><td>1&#x000a0;U/&#x003bc;L</td><td>25&#x000a0;&#x003bc;L</td></tr><tr><td>Nuclease-free Water</td><td>N/A</td><td>924&#x000a0;&#x003bc;L</td></tr><tr><td><bold>Total</bold></td><td><bold>N/A</bold></td><td><bold>1&#x000a0;mL</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Make solution immediately before use.</p></fn></table-wrap-foot></table-wrap>
<table-wrap position="float" id="undtbl8"><caption><p>Wash buffer</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Reagent</th><th>Final concentration</th><th>Amount</th></tr></thead><tbody><tr><td>Tris-HCl (pH 7.4, 1 M)</td><td>10&#x000a0;mM</td><td>40&#x000a0;&#x003bc;L</td></tr><tr><td>NaCl (5 M)</td><td>10&#x000a0;mM</td><td>8&#x000a0;&#x003bc;L</td></tr><tr><td>MgCl2 (1 M)</td><td>3&#x000a0;mM</td><td>12&#x000a0;&#x003bc;L</td></tr><tr><td>BSA (10%)</td><td>1%</td><td>400&#x000a0;&#x003bc;L</td></tr><tr><td>Tween-20 (10%)</td><td>0.10%</td><td>40&#x000a0;&#x003bc;L</td></tr><tr><td>DTT (1 M)</td><td>1&#x000a0;mM</td><td>4&#x000a0;&#x003bc;L</td></tr><tr><td>RNAse inhibitor (40&#x000a0;U/ &#x003bc;L)</td><td>1&#x000a0;U/&#x003bc;L</td><td>100&#x000a0;&#x003bc;L</td></tr><tr><td>Nuclease-free Water</td><td>N/A</td><td>3.40&#x000a0;mL</td></tr><tr><td><bold>Total</bold></td><td><bold>N/A</bold></td><td><bold>4&#x000a0;mL</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Make solution immediately before use.</p></fn></table-wrap-foot></table-wrap>
<table-wrap position="float" id="undtbl9"><caption><p>Lysis buffer</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Reagent</th><th>Final concentration</th><th>Amount</th></tr></thead><tbody><tr><td>Tris-HCl (pH 7.4, 1 M)</td><td>10&#x000a0;mM</td><td>20&#x000a0;&#x003bc;L</td></tr><tr><td>NaCl (5 M)</td><td>10&#x000a0;mM</td><td>4&#x000a0;&#x003bc;L</td></tr><tr><td>MgCl2 (1 M)</td><td>3&#x000a0;mM</td><td>6&#x000a0;&#x003bc;L</td></tr><tr><td>Tween-20 (10%)</td><td>0.10%</td><td>20&#x000a0;&#x003bc;L</td></tr><tr><td>Nonidet P40 Substitute (10%)</td><td>0.10%</td><td>20&#x000a0;&#x003bc;L</td></tr><tr><td>Digitonin (5%)</td><td>0.01%</td><td>4&#x000a0;&#x003bc;L</td></tr><tr><td>BSA (10%)</td><td>1%</td><td>200&#x000a0;&#x003bc;L</td></tr><tr><td>DTT (1 M)</td><td>1&#x000a0;mM</td><td>2&#x000a0;&#x003bc;L</td></tr><tr><td>RNase inhibitor (40&#x000a0;U/ &#x003bc;L)</td><td>1&#x000a0;U/&#x003bc;L</td><td>50&#x000a0;&#x003bc;L</td></tr><tr><td>Nuclease-free Water</td><td>N/A</td><td>1.67&#x000a0;mL</td></tr><tr><td><bold>Total</bold></td><td><bold>N/A</bold></td><td><bold>2&#x000a0;mL</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Make solution immediately before use.</p></fn></table-wrap-foot></table-wrap>
<table-wrap position="float" id="undtbl10"><caption><p>Transposition mix</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Reagent</th><th>Amount</th></tr></thead><tbody><tr><td>TAC Buffer B</td><td>7&#x000a0;&#x003bc;L</td></tr><tr><td>TAC Enzyme B</td><td>3&#x000a0;&#x003bc;L</td></tr><tr><td><bold>Total</bold></td><td><bold>10&#x000a0;&#x003bc;L</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Make solution immediately before use.</p></fn></table-wrap-foot></table-wrap>
<table-wrap position="float" id="undtbl11"><caption><p>GEM master mix</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Reagent</th><th>Amount</th></tr></thead><tbody><tr><td>Barcoding Reagent Mix</td><td>49.5&#x000a0;&#x003bc;L</td></tr><tr><td>Template Switch Oligo</td><td>1.1&#x000a0;&#x003bc;L</td></tr><tr><td>Reducing Agent B</td><td>1.9&#x000a0;&#x003bc;L</td></tr><tr><td>Barcoding Enzyme Mix</td><td>7.5&#x000a0;&#x003bc;L</td></tr><tr><td><bold>Total</bold></td><td><bold>60&#x000a0;&#x003bc;L</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Make solution immediately before use.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="sec3"><title>Step-by-step method details</title><sec id="sec3.1"><title>Processing of ovarian tumor to single-cell suspensions</title><p id="p0140">
<disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: &#x0223c;1 h</bold></p></disp-quote>
<list list-type="simple" id="olist0025"><list-item id="o0080"><label>1.</label><p id="p0145">Pour fresh tumor sample into plastic petri dish previously pre-scoured with scalpels (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>).<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Steps for the generation of single-cell suspension from tumor biopsies</p><p>Representative photographs of the used materials. 1) Scoured petri dish to press the tumor. 2) Filter first through a 100&#x000a0;&#x003bc;m nylon cell strainer. 3) Add RBC lysis buffer for 5&#x000a0;min. 4) Filter after centrifugation through a 70&#x000a0;&#x003bc;m nylon cell strainer.5) Count the single cell suspension. 6) Freeze in Mr. Frostis.</p></caption><graphic xlink:href="gr1"/></fig></p></list-item><list-item id="o0085"><label>2.</label><p id="p0150">Use the plastic part of a plunger from a 10&#x000a0;mL syringe to gently press the minced tumor on the scoured petri dish, trying to be as careful as possible using the plastic part and not the rubber part of the plunger.</p></list-item><list-item id="o0090"><label>3.</label><p id="p0155">Filter tumor mash through a 100&#x000a0;&#x003bc;m nylon cell strainer. Use plunger from the 1&#x000a0;mL syringe to press through.</p></list-item></list>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> Pass media through strainer also to help mash through filter.</p></disp-quote>
<list list-type="simple" id="olist0030"><list-item id="o0095"><label>4.</label><p id="p0160">Centrifuge sample at 500&#x000a0;&#x000d7;&#x000a0;<italic>g</italic> at 4&#x000b0;C for 5&#x000a0;min and aspirate/pour off media to remove debris and dead cells.</p></list-item></list>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> All media/material waste from sample is treated in at least 10% bleach.</p></disp-quote>
<list list-type="simple" id="olist0035"><list-item id="o0100"><label>5.</label><p id="p0165">Add 5&#x02013;10&#x000a0;mL of RBC lysis buffer and resuspend the pellet. Incubate for 5&#x000a0;min with rotation at RT.</p></list-item></list>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> Longer incubation times could significantly affect to the viability of the immune cells.</p></disp-quote>
<list list-type="simple" id="olist0040"><list-item id="o0105"><label>6.</label><p id="p0170">Add 10&#x000a0;mL R10 media to stop the RBC lysis reaction.</p></list-item><list-item id="o0110"><label>7.</label><p id="p0175">Centrifuge sample at 500&#x000a0;&#x000d7;&#x000a0;<italic>g</italic> at 4&#x000b0;C for 5&#x000a0;min and aspirate/pour off media to remove debris and dead cells.</p></list-item><list-item id="o0115"><label>8.</label><p id="p0180">Next, fully re-suspend pellet in fresh R10 media and pass through a 70&#x000a0;&#x003bc;m strainer in a new 50&#x000a0;mL conical tube.</p></list-item><list-item id="o0120"><label>9.</label><p id="p0185">Calculate the total viable cell number using trypan blue solution and the Neubauer chamber. Spin down sample at 500&#x000a0;&#x000d7;&#x000a0;<italic>g</italic> at 4&#x000b0;C for 5&#x000a0;min while counting cells.</p></list-item><list-item id="o0125"><label>10.</label><p id="p0190">Remove supernatant completely and re-suspend in freezing media.</p></list-item></list>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> We recommend to resuspend the pellet at a density of maximum 5&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> cells/mL in freezing medium (from 5&#x000a0;&#x000d7;&#x000a0;10<sup>5</sup> to 10&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> per cryovial).</p></disp-quote>
<list list-type="simple" id="olist0045"><list-item id="o0130"><label>11.</label><p id="p0195">Store samples in Mr. Frosty, remove from &#x02212;80&#x000b0;C the next morning and transfer into LN2 tank.</p></list-item></list>
</p></sec><sec id="sec3.2"><title>Prepare sample for FACs sorting prior to encapsulation</title><p id="p0200">
<disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: &#x0223c;5 h</bold></p></disp-quote>
<list list-type="simple" id="olist0050"><list-item id="o0135"><label>12.</label><p id="p0205">Warm &#x0223c;5&#x000a0;mL of complete culture medium in a 37&#x000b0;C water bath.</p></list-item><list-item id="o0140"><label>13.</label><p id="p0210">Thaw one vial of ovarian tumor cells rapidly in a 37&#x000b0;C water bath with gentle agitation.<list list-type="simple" id="olist0055"><list-item id="o0145"><label>a.</label><p id="p0215">Immediately upon thawing, remove from the water bath and wipe the outside of the vial with 70% ethanol.</p></list-item><list-item id="o0150"><label>b.</label><p id="p0220">Unscrew the top of the vial slowly and, using 1&#x000a0;mL pipet, transfer the contents of the vial to a 15-mL conical centrifuge tube containing &#x0223c;5&#x000a0;mL of prewarmed medium.</p></list-item><list-item id="o0155"><label>c.</label><p id="p0225">Mix gently.</p></list-item></list></p></list-item><list-item id="o0160"><label>14.</label><p id="p0230">Remove the freezing media.<list list-type="simple" id="olist0060"><list-item id="o0165"><label>a.</label><p id="p0235">Centrifuge at 500&#x000a0;&#x000d7;&#x000a0;<italic>g</italic> for 5&#x000a0;min, 4&#x000b0;C.</p></list-item><list-item id="o0170"><label>b.</label><p id="p0240">Carefully aspirate the supernatant, and gently resuspend the cells in &#x0223c;5&#x000a0;mL of complete medium.</p></list-item><list-item id="o0175"><label>c.</label><p id="p0245">Filter the single cell suspension through a 70&#x000a0;&#x003bc;m nylon cell strainer. Pass another 5&#x000a0;mL of media through the filter.</p></list-item></list></p></list-item><list-item id="o0180"><label>15.</label><p id="p0250">Wash the cells a second time.<list list-type="simple" id="olist0065"><list-item id="o0185"><label>a.</label><p id="p0255">Centrifuge at 500&#x000a0;&#x000d7;&#x000a0;<italic>g</italic> for 5&#x000a0;min, 4&#x000b0;C.</p></list-item><list-item id="o0190"><label>b.</label><p id="p0260">Carefully aspirate the supernatant, and gently resuspend the cells in &#x0223c;5&#x000a0;mL of complete medium.</p></list-item><list-item id="o0195"><label>c.</label><p id="p0265">Filter the single cell suspension through a 45&#x000a0;&#x003bc;m nylon cell strainer. Pass another 5&#x000a0;mL of media through the filter.</p></list-item></list></p></list-item><list-item id="o0200"><label>16.</label><p id="p0270">Calculate the total cell number.<list list-type="simple" id="olist0070"><list-item id="o0205"><label>a.</label><p id="p0275">Centrifuge at 500&#x000a0;&#x000d7;&#x000a0;<italic>g</italic> for 5&#x000a0;min, 4&#x000b0;C.</p></list-item><list-item id="o0210"><label>b.</label><p id="p0280">Carefully aspirate the supernatant, and gently resuspend the cells in &#x0223c;5&#x000a0;mL of complete medium.</p></list-item><list-item id="o0215"><label>c.</label><p id="p0285">Count the total number of cells.</p></list-item></list></p></list-item></list>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> Keep the cells on ice while counting.</p></disp-quote>
<list list-type="simple" id="olist0075"><list-item id="o0220"><label>17.</label><p id="p0290">Fill the tube with dead cell removal Kit buffer and centrifuge at 500&#x000a0;&#x000d7;&#x000a0;<italic>g</italic> for 5&#x000a0;min, 4&#x000b0;C and resuspend the pellet at a density of at 1&#x000a0;&#x000d7;&#x000a0;108 cells/mL.</p></list-item><list-item id="o0225"><label>18.</label><p id="p0295">Follow the instructions of the manufacturer: <ext-link ext-link-type="uri" xlink:href="https://www.stemcell.com/products/easysep-dead-cell-removal-annexin-v-kit" id="intref0020">https://www.stemcell.com/products/easysep-dead-cell-removal-annexin-v-kit</ext-link>.</p></list-item><list-item id="o0230"><label>19.</label><p id="p0300">Pipette the 2.5&#x000a0;mL of enriched cell suspension into a new 15&#x000a0;mL tube and fill up the tube with 10&#x000a0;mL of sorting buffer.</p></list-item><list-item id="o0235"><label>20.</label><p id="p0305">Centrifuge and resuspend the pellet.<list list-type="simple" id="olist0080"><list-item id="o0240"><label>a.</label><p id="p0310">Take an aliquot for counting and wash again with sorting buffer.</p></list-item><list-item id="o0245"><label>b.</label><p id="p0315">Resuspend the pellet at 1&#x000a0;&#x000d7;&#x000a0;106 cells in 100&#x000a0;&#x003bc;L of sorting buffer with Human TruStain FcX (5&#x000a0;&#x003bc;L/100&#x000a0;&#x003bc;L).</p></list-item></list></p></list-item></list>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> Since the viability is very important, centrifuge always at 4&#x000b0;C and keep the sample on ice during waiting times, unless otherwise specified.</p></disp-quote>
<list list-type="simple" id="olist0085"><list-item id="o0250"><label>21.</label><p id="p0320">Incubate 10&#x000a0;min at RT and add the antibodies for sorting: CD45, CD3, CD4, CD8, CD69 and CD103. Incubate for 1&#x000a0;h at 4&#x000b0;C in the dark.</p></list-item></list>
<disp-quote><p><bold><italic>Note:</italic></bold> Prepare a mix with antibodies in sorting buffer at 5:100, then add to the samples (1&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> cells in 100&#x000a0;&#x003bc;L) for final antibody dilution of 5:200.</p></disp-quote>
<list list-type="simple" id="olist0090"><list-item id="o0255"><label>22.</label><p id="p0325">After 1&#x000a0;h of incubation, wash the cells with sorting buffer.<list list-type="simple" id="olist0095"><list-item id="o0260"><label>a.</label><p id="p0330">Resuspend the cells at approx. 5&#x000a0;&#x000d7;&#x000a0;106 cells/mL.</p></list-item><list-item id="o0265"><label>b.</label><p id="p0335">Filter again through a 40&#x000a0;&#x003bc;m filter to avoid clumps and add DAPI at a final concentration 100&#x000a0;ng/mL.</p></list-item></list></p></list-item></list>
<disp-quote><p><bold><italic>Note:</italic></bold> We use BD FACS ARIA for sorting but another sorter like MACSQuant&#x000ae; Tyto&#x000ae; could be also.</p></disp-quote>
<list list-type="simple" id="olist0100"><list-item id="o0270"><label>23.</label><p id="p0340">Setup the sorter. We use 20 psi with a 100&#x000a0;&#x003bc;m nozzle.</p></list-item><list-item id="o0275"><label>24.</label><p id="p0345">Set the gates for singlets, viable, CD45+, CD3+ CD8+; CD69+CD103+ for TRM cells and CD69+/-CD103- for recirculating T&#x000a0;cells (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>).<fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>FACS sorting gating strategy for TRM CD8<sup>+</sup> TILs and their re-circulating counterpart</p><p>Dot plots show gates in a hirarchical order: P1 (SSC-A/FSC-A; lymphocytes according to size and granularity); P2 (FSC-H/FSC-A; singlets); P3 (DAPI/FSC-A; live cells); P4 (CD45/CD3; T&#x000a0;cells); P5 (CD8/CD4; CD8<sup>+</sup> T&#x000a0;cells); P6 and P7 (CD103/CD69; TRM CD8<sup>+</sup> TILs and re-circulating CD8<sup>+</sup> T&#x000a0;cells, respectively).</p></caption><graphic xlink:href="gr2"/></fig></p></list-item></list>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> Use 1.5&#x000a0;mL Eppendorf for recollection since the number of sorted cells is low. Use filtered FBS as a recollection buffer to increase cell viability of sorted cells. However, it is important to have everything ready that you need after sorting to proceed and not leave the cells on ice for long.</p></disp-quote>
<disp-quote><p><bold><italic>Note:</italic></bold> If number of cells is high, it is good to verify the cell purity using flow cytometry.</p></disp-quote>
</p></sec><sec id="sec3.3"><title>Prepare cells for encapsulation and following steps of single-cell RNA-seq + VDJ profiling</title><p id="p0350">
<disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: &#x0223c;10&#x000a0;min</bold></p></disp-quote>
<list list-type="simple" id="olist0105"><list-item id="o0280"><label>25.</label><p id="p0355">After sorting, fill up the Eppendorf tube with cells with 1&#x000a0;mL resuspension solution.</p></list-item><list-item id="o0285"><label>26.</label><p id="p0360">Centrifuge 300&#x000a0;g for 5&#x000a0;min and resuspend the pellet to the concentration of 700&#x02013;1,200 cells/uL.</p></list-item><list-item id="o0290"><label>27.</label><p id="p0365">Add 10 ul cell suspension to 10 ul AO/PI staining solution and visualize on Nexcelon cellometer Auto 2K. Repeat the cell count two more times for a total of 3 times if cell number permits. The viability should be at least &#x0003e;70%.</p></list-item><list-item id="o0295"><label>28.</label><p id="p0370">Adjust the cell concentration with resuspension buffer if needed.</p></list-item></list>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> If total cell number is less than required input cell number, centrifuge the cell suspension and remove the supernatant to make the final volume around 25 ul and use all for encapsulation.</p></disp-quote>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> Do not exceed the number of cells allowed by 10&#x000d7; per encapsulation (10,000 cells). The doublets rate increase by 0.8% every 1,000 cells.</p></disp-quote>
<list list-type="simple" id="olist0110"><list-item id="o0300"><label>29.</label><p id="p0375">Follow the cell suspension volume calculator table (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>) to load the cells onto the 10&#x000d7; Genomics Chromium Single Cell Controller.<table-wrap position="float" id="tbl1"><label>Table&#x000a0;1</label><caption><p>Cell suspension volume calculator table</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Cell stock concentration (cells/&#x003bc;L)</th><th colspan="11">Targeted cell recovery<hr/></th></tr><tr><th>500</th><th>1,000</th><th>2,000</th><th>3,000</th><th>4,000</th><th>5,000</th><th>6,000</th><th>7,000</th><th>8,000</th><th>9,000</th><th>10,000</th></tr></thead><tbody><tr><td>700</td><td>1.2</td><td>2.4</td><td>4.7</td><td>7.1</td><td>9.4</td><td>11.8</td><td>14.1</td><td>16.5</td><td>18.9</td><td>21.2</td><td>23.6</td></tr><tr><td>800</td><td>1</td><td>2.1</td><td>4.1</td><td>6.2</td><td>8.3</td><td>10.3</td><td>12.4</td><td>14.4</td><td>16.5</td><td>18.6</td><td>20.6</td></tr><tr><td>900</td><td>0.9</td><td>1.8</td><td>3.7</td><td>5.5</td><td>7.3</td><td>9.2</td><td>11</td><td>12.8</td><td>14.7</td><td>16.5</td><td>18.3</td></tr><tr><td>1,000</td><td>0.8</td><td>1.7</td><td>3.3</td><td>5</td><td>6.6</td><td>8.3</td><td>9.9</td><td>11.6</td><td>13.2</td><td>14.9</td><td>16.5</td></tr><tr><td>1,100</td><td>0.8</td><td>1.5</td><td>3</td><td>4.5</td><td>6</td><td>7.5</td><td>9</td><td>10.5</td><td>12</td><td>13.5</td><td>15</td></tr><tr><td>1,200</td><td>0.7</td><td>1.4</td><td>2.8</td><td>4.1</td><td>5.5</td><td>6.9</td><td>8.3</td><td>9.6</td><td>11</td><td>12.4</td><td>13.8</td></tr></tbody></table></table-wrap></p></list-item><list-item id="o0305"><label>30.</label><p id="p0380">Follow the manufacturing recommendations: <ext-link ext-link-type="uri" xlink:href="https://www.10xgenomics.com/support/single-cell-gene-expression/documentation/steps/library-prep/chromium-single-cell-3-reagent-kits-user-guide-v-3-1-chemistry" id="intref0025">https://www.10xgenomics.com/support/single-cell-gene-expression/documentation/steps/library-prep/chromium-single-cell-3-reagent-kits-user-guide-v-3-1-chemistry</ext-link>. Encapsulate the single cells, reagents, and 10&#x000d7; Genomics gel beads into individual nanoliter-sized Gelbeads in Emulsion (GEMs) and then perform reverse transcription of poly-adenylated mRNA inside each droplet.</p></list-item><list-item id="o0310"><label>31.</label><p id="p0385">Complete the cDNA and VDJ-enriched libraries in a single bulk reaction using the 10&#x000d7; Genomics Chromium NextGEM Single Cell 5&#x02032; v 1.1 and V(D)J Reagent Kits.</p></list-item></list>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> Run 1&#x000a0;&#x003bc;L library on the Agilent Bioanalyzer High Sensitive DNA chip to determine fragment size. Low molecular weight product (=&#x0003c;150&#x000a0;bp) and /or a high molecular weight product (&#x0003e;&#x000a0;= 200&#x000a0;bp) may be present. This does not affect sequencing.</p></disp-quote>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> Generate 50,000 or 5,000 sequencing reads per cell for scRNA-seq or VDJ libraries, respectively, on the Illumina NextSeq 500 or NextSeq 2000 instruments.</p></disp-quote>
<list list-type="simple" id="olist0115"><list-item id="o0315"><label>32.</label><p id="p0390">Perform demultiplexing, barcode processing, alignment, and gene counting using the 10&#x000d7; Genomics CellRanger v6.1.2 software.</p></list-item></list>
</p></sec><sec id="sec3.4"><title>Prepare cells for encapsulation and following steps of Multiome</title><p id="p0395">
<disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: &#x0223c;3&#x000a0;days</bold></p></disp-quote>
<list list-type="simple" id="olist0120"><list-item id="o0320"><label>33.</label><p id="p0400">After sorting, prepare the cell suspension the same way as single cell RNAseq+VDJ protocol: use 100,000&#x02013;1,000,000 cells for lysis.</p></list-item><list-item id="o0325"><label>34.</label><p id="p0405">Lyse the cells, and isolate and dilute nuclei in diluted nuclei buffer according to the manufacturer&#x02019;s protocol: <ext-link ext-link-type="uri" xlink:href="https://www.10xgenomics.com/support/single-cell-multiome-atac-plus-gene-expression/documentation/steps/sample-prep/chromium-nuclei-isolation-kit-sample-prep-user-guide" id="intref0030">https://www.10xgenomics.com/support/single-cell-multiome-atac-plus-gene-expression/documentation/steps/sample-prep/chromium-nuclei-isolation-kit-sample-prep-user-guide</ext-link>.</p></list-item><list-item id="o0330"><label>35.</label><p id="p0410">Add 10 ul nuclei suspension to 10 ul AO/PI staining solution and visualize on Nexcelon cellometer Auto 2K. Repeat the nuclei count two more times for a total of 3 times if nuclei number permits.</p></list-item></list>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> After lysis, the optimal viability should be 2%&#x02013;10%. The cells are underlysed if viability &#x0003e;10%, overlysed if viability &#x0003c;2%.</p></disp-quote>
<list list-type="simple" id="olist0125"><list-item id="o0335"><label>36.</label><p id="p0415">Adjust the nuclei concentration with Diluted Nuclei buffer following the table (<xref rid="tbl2" ref-type="table">Table&#x000a0;2</xref>) if needed:<table-wrap position="float" id="tbl2"><label>Table&#x000a0;2</label><caption><p>Nuclei concentration table</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Targeted nuclei recovery</th><th>Nuclei concentration (nuclei/ul)</th></tr></thead><tbody><tr><td>500</td><td>160&#x02013;400</td></tr><tr><td>1,000</td><td>320&#x02013;810</td></tr><tr><td>2,000</td><td>650&#x02013;1,610</td></tr><tr><td>3,000</td><td>972&#x02013;2,420</td></tr><tr><td>4,000</td><td>1,290&#x02013;3,230</td></tr><tr><td>5,000</td><td>1,610&#x02013;4,230</td></tr><tr><td>6,000</td><td>1,940&#x02013;4,840</td></tr><tr><td>7,000</td><td>2,260&#x02013;5,650</td></tr><tr><td>8,000</td><td>2,580&#x02013;6,450</td></tr><tr><td>9,000</td><td>2,900&#x02013;7,260</td></tr><tr><td>10,000</td><td>3,230&#x02013;8,060</td></tr></tbody></table></table-wrap></p></list-item><list-item id="o0340"><label>37.</label><p id="p0420">Encapsulate the nuclei, reagents, and 10&#x000d7; Genomics gel beads into individual nanoliter-sized Gelbeads in Emulsion (GEMs) and then perform reverse transcription of poly-adenylated mRNA and 10&#x000d7; barcode attachment of transposed DNA inside each droplet.</p></list-item><list-item id="o0345"><label>38.</label><p id="p0425">Following pre-amplification, complete the cDNA and ATAC-seq libraries in a single bulk reaction using the 10&#x000d7; Genomics Chromium NextGEM Single Cell Multiome ATAC&#x000a0;+ Gene Expression Reagent Kit.</p></list-item><list-item id="o0350"><label>39.</label><p id="p0430">Generate 50,000 or 25,000 sequencing reads per cell for scRNA-seq or ATAC-seq libraries, respectively, on dedicated Illumina NextSeq 500 or NextSeq 2000 sequencing runs according to the vendor protocol: <ext-link ext-link-type="uri" xlink:href="https://support.illumina.com/downloads/nextseq-500-user-guide-15046563.html" id="intref0035">https://support.illumina.com/downloads/nextseq-500-user-guide-15046563.html</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://support.illumina.com/downloads/nextseq-2000-sequencing-system-guide-1000000109376.html" id="intref0040">https://support.illumina.com/downloads/nextseq-2000-sequencing-system-guide-1000000109376.html</ext-link>.</p></list-item><list-item id="o0355"><label>40.</label><p id="p0435">Perform demultiplexing, barcode processing, alignment, and gene counting using the 10&#x000d7; Genomics CellRanger v6.1.2 software.</p></list-item></list>
</p></sec><sec id="sec3.5"><title>Integration of single-cell RNA-seq data from different samples</title><p id="p0440">
<disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: 2&#x000a0;days</bold></p></disp-quote>
<list list-type="simple" id="olist0130"><list-item id="o0360"><label>41.</label><p id="p0445">The sorted TRM and recirculating CD8+ T&#x000a0;cells from different patients were encapsulated individually, which posed an unique challenge to the downstream analysis.<list list-type="simple" id="olist0135"><list-item id="o0365"><label>a.</label><p id="p0450">It is important to correct for the batch effects while maintaining the biological differences between TRM and recirculating CD8+ T&#x000a0;cells within the same patient.</p></list-item><list-item id="o0370"><label>b.</label><p id="p0455">Below we provide a two-stage analytical plan for integrating sorted TRM and recirculating CD8+ T&#x000a0;cells across patients using R package Seurat (<xref rid="bib6" ref-type="bibr">Stuart et&#x000a0;al., 2019</xref>).</p></list-item></list></p></list-item></list>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> For this analysis the filtered gene-barcodes matrices generated by CellRanger are required. These matrices are formatted either as filtered_feature_bc_matrix.h5 or a folder named as filtered_feature_bc_matrix.</p></disp-quote>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> This script first merges data from TRM and recirculating CD8+ T&#x000a0;cells within the same patient, and then integrates merged data across patients. This is based on the assumptions that all patients have similar level of heterogeneity in the merged TRM recirculating CD8+ T&#x000a0;cells. It is advised to examine whether the assumption holds in data, before using this script.</p></disp-quote>
<list list-type="simple" id="olist0140"><list-item id="o0375"><label>42.</label><p id="p0460">Processing the individual single-cell RNA-seq data. For each sample:<list list-type="simple" id="olist0145"><list-item id="o0380"><label>a.</label><p id="p0465">Load the filtered gene-barcodes matrices generated by CellRanger to Seurat.</p></list-item><list-item id="o0385"><label>b.</label><p id="p0470">Remove cells with less than 200 genes expressed or more than 10% UMIs originated from mitochondrial genes.</p></list-item><list-item id="o0390"><label>c.</label><p id="p0475">Remove genes expressed in less than three cells.</p></list-item></list></p></list-item></list>
<boxed-text id="dtbox1"><p id="p0480">
&#x0003e;install.packages("Seurat")
</p><p id="p0485">
&#x0003e;library(Seurat)
</p><p id="p0490">
&#x0003e;P1_ReCir_h5&#x000a0;&#x0003c;- Read10X_h5("filtered_feature_bc_matrix.h5")
</p><p id="p0495">
&#x0003e;P1_ReCir &#x0003c;- CreateSeuratObject(P1_ReCir_h5, min.cells&#x000a0;= 3)
</p><p id="p0500">
&#x0003e;P1_ReCir$percent.mt &#x0003c;- PercentageFeatureSet(P1_ReCir, pattern&#x000a0;= "&#x002c6;MT-")
</p><p id="p0505">
&#x0003e;P1_ReCir &#x0003c;- subset(P1_ReCir, subset&#x000a0;= nFeature_RNA&#x000a0;&#x0003e;&#x000a0;200 &#x00026; percent.mt&#x000a0;&#x0003c;&#x000a0;10
</p></boxed-text>
<list list-type="simple" id="olist0150"><list-item id="o0395"><label>43.</label><p id="p0510">Repeat above steps for all TRM and recirculating single-cell RNA-seq data.</p></list-item><list-item id="o0400"><label>44.</label><p id="p0515">Merge TRM and recirculating data from the same patient.</p></list-item></list>
<boxed-text id="dtbox2"><p id="p0520">
&#x0003e;P1&#x000a0;&#x0003c;- merge(P1_TRM, P1_ReCir, add.cell.ids&#x000a0;= c("P1_TRM", "P1_ReCir"), project&#x000a0;= "P1&#x0201d;)
</p><p id="p0525">
&#x0003e;P1&#x000a0;&#x0003c;- NormalizeData(P1)
</p><p id="p0530">
&#x0003e;P1&#x000a0;&#x0003c;- FindVariableFeatures(P1, selection.method&#x000a0;= "vst", nfeatures&#x000a0;= 5000)
</p><p id="p0535">
Vgene &#x0003c;- VariableFeatures(P1)
</p><p id="p0540">
P1[["RNA"]]@var.features &#x0003c;- Vgene[!grepl("&#x002c6;IG",Vgene) &#x00026; !grepl("&#x002c6;TR",Vgene))]
</p></boxed-text>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> To avoid cell clustering by V(D)J transcripts, it is important to remove T&#x000a0;cell receptor and immunoglobulin genes from variable gene list of each merged data.</p></disp-quote>
<list list-type="simple" id="olist0155"><list-item id="o0405"><label>45.</label><p id="p0545">Repeat above step for all patients.</p></list-item><list-item id="o0410"><label>46.</label><p id="p0550">Integrate merged data across different patients.</p></list-item></list>
<boxed-text id="dtbox3"><p id="p0555">
&#x0003e;anchors &#x0003c;- FindIntergrationAnchors(object.list&#x000a0;= list(P1, P2, P3, P4), dims&#x000a0;= 1:40, anchor.features&#x000a0;= 8000)
</p><p id="p0560">
&#x0003e;integrated &#x0003c;- IntegrateData(anchorset&#x000a0;= anchors, dims&#x000a0;= 1:40)
</p></boxed-text>
<list list-type="simple" id="olist0160"><list-item id="o0415"><label>47.</label><p id="p0565">Scale the integrated data and perform clustering analysis.</p></list-item></list>
<boxed-text id="dtbox4"><p id="p0570">
&#x0003e;cc.genes &#x0003c;- readLines(con&#x000a0;= &#x0201c;regev_lab_cell_cycle_genes.txt&#x0201d;)
</p><p id="p0575">
&#x0003e;integrated &#x0003c;- CellCycleScoring(object&#x000a0;= integrated, s.features&#x000a0;= cc.genes[1:43], g2m.features&#x000a0;= cc.genes[44:97])
</p><p id="p0580">
&#x0003e;integrated &#x0003c;- ScaleData(object&#x000a0;= integrated, vars.to.regress&#x000a0;= c("percent.mt","S.Score", "G2M.Score"))
</p><p id="p0585">
&#x0003e;integrated &#x0003c;- RunPCA(integrated, verbose&#x000a0;= FALSE, npcs&#x000a0;= 50)
</p><p id="p0590">
&#x0003e;integrated &#x0003c;- RunUMAP(integrated, dims&#x000a0;= 1:40, reduction&#x000a0;= "pca",verbose&#x000a0;= FALSE)
</p><p id="p0595">
&#x0003e;integrated &#x0003c;- FindNeighbors(object&#x000a0;= integrated, dims&#x000a0;= 1:40)
</p><p id="p0600">
&#x0003e;integrated &#x0003c;- FindClusters(object&#x000a0;= integrated, reduction&#x000a0;= "pca", resolution&#x000a0;=1)
</p><p id="p0605">
&#x0003e;saveRDS(integrated, "integrated.rds")
</p></boxed-text>
<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> The FindClusters parameter <italic>resolution</italic> should be decided based on heterogeneity levels within user&#x02019;s own datasets. For datasets of sorted CD8+ tumor resistant memory T&#x000a0;cells, we recommend resolution ranges from 0.8 to 1.2. For more heterrogenious samples (for example, sorted tumor infiltrating T&#x000a0;cells), larger resolution (1.5&#x02013;2) might be used.</p></disp-quote>
</p></sec><sec id="sec3.6"><title>Identification of T&#x000a0;cell trajectory</title><p id="p0610">
<disp-quote><p><inline-graphic xlink:href="fx2.gif"/><bold>Timing: 2&#x000a0;days</bold></p></disp-quote>
</p><p id="p0615">The following steps include the analysis of T&#x000a0;cell differentiation trajectory: Recirculating&#x02192;TRMstem &#x02192; TRMeffector &#x02192; TRMproliferative &#x02192; TRMexhaustive. Please see <ext-link ext-link-type="uri" xlink:href="https://github.com/xxy39/TRM_OV_sc" id="intref0045">https://github.com/xxy39/TRM_OV_sc</ext-link> (<ext-link ext-link-type="doi" xlink:href="10.5281/zendo.6828033" id="intref0050">https://doi.org/10.5281/zendo.6828033</ext-link>) for the detailed scripts.<list list-type="simple" id="olist0165"><list-item id="o0420"><label>48.</label><p id="p0620">Assign T&#x000a0;cell differentiation states to clusters using markers derived from Anadon et&#x000a0;al. (<xref rid="bib2" ref-type="bibr">Anadon et&#x000a0;al., 2022</xref>), following script deposited at GitHub <ext-link ext-link-type="uri" xlink:href="https://github.com/xxy39/TRM_OV_sc/blob/main/DiffPlot.R" id="intref0055">https://github.com/xxy39/TRM_OV_sc/blob/main/DiffPlot.R</ext-link>.<list list-type="simple" id="olist0170"><list-item id="o0425"><label>a.</label><p id="p0625">Calculate gene set activity scores for stemness, effector, proliferative, and exhaustive T&#x000a0;cell differentiation states using R package <italic>AUCell</italic> (<xref rid="bib1" ref-type="bibr">Aibar et&#x000a0;al., 2017</xref>). Marker genes for each differentiation states are shown in table (<xref rid="tbl3" ref-type="table">Table&#x000a0;3</xref>) below.<table-wrap position="float" id="tbl3"><label>Table&#x000a0;3</label><caption><p>Marker genes for each differentiation state</p></caption><table frame="hsides" rules="groups"><thead><tr><th>States</th><th>Genes</th></tr></thead><tbody><tr><td>Stemness</td><td>SELL, LEF1, CD28, CD27, CCR7, IL7R, CXCR5, TCF7, BACH2, JUNB, EGR1, KLF2</td></tr><tr><td>Activation</td><td>IL2, CD38, ENTPD1, ICOS, TNFRSF9, XCL1</td></tr><tr><td>Effector</td><td>GZMK, GZMH, GZMB, PRF1, GNLY, IFNG, FASLG, FGFBP2</td></tr><tr><td>TRM differentiation</td><td>ITGA1, ITGAE, ITGA2, ITGAL, ITGB2</td></tr><tr><td>Proliferative</td><td>TOP2A, MKI67, CDK1, STMN1, DNMT1, MCM7</td></tr><tr><td>Exhaustive</td><td>PDCD1, TIGIT, HAVCR2, LAG3, CTLA4, CD74, MIR155HG, CXCL13, LAYN, MYO7A, HLA-DRB1, HLA-DQA1, TOX, TOX2, BATF, ETV1, ID2, ZNF683, RBPJ, TBX21, RUNX1, RUNX3, RUNX2, EZH2</td></tr></tbody></table></table-wrap></p></list-item><list-item id="o0430"><label>b.</label><p id="p0630">Generate a cluster-based dotplot for activity scores (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>A). Determine cell type of each cluster based on the average activity score and percentage of cells expressing the genes.<fig id="fig3"><label>Figure&#x000a0;3</label><caption><p>Identify T&#x000a0;cell differentiation trajectory from TRM and recirculating CD8+ T&#x000a0;cells using single-cell RNA/TCR/ATAC-seq data</p><p>(A) AUCell scores for T&#x000a0;cell states stemness/effector/proliferative/exhaustive in clusters. Color of dot presents the average normalized expression from high (red) to low (blue). Size of dot represents the percentage of positive cells for each gene.</p><p>(B) Stemness score versus Exhaustion score from all the clusters. Color represents the percentage of TRM cells within each cluster. Size represents number of cells of each cluster.</p><p>(C) AUCell scores by 8 groups. Within each of groups &#x0201c;Stemlike&#x0201d;, &#x0201c;Effector&#x0201d;, &#x0201c;Proliferative&#x0201d;, and &#x0201c;Exhausted&#x0201d;, cells were separated based on cell types (TRM or recirculating).</p><p>(D) Heatmap of Morisita-Horn similarity of the 5 major groups identified based on gene expression.</p><p>(E) Example of clonotype with full trajectory. Cells are projected onto the UMAP generated from gene expression and cells of a particular clonotype are colored by their groups.</p><p>(F) Gene activity of T&#x000a0;cell differentiation states genes measured in ATAC assay of Multiome data. Color of dot presents the average normalized gene activity from high (red) to low (blue). Size of dot represents the percentage of positive cells for each gene.</p></caption><graphic xlink:href="gr3"/></fig></p></list-item><list-item id="o0435"><label>c.</label><p id="p0635">Plot the relationship between stemness and exhaustive scores for clusters (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B). This step helps to exam major cell type (TRM or Recirculating) in each cluster. The proliferative and exhaustive clusters tend to have higher TRM %, while stemness clusters tend to have lower TRM %. In the example data shown in <ext-link ext-link-type="uri" xlink:href="https://github.com/xxy39/TRM_OV_sc" id="intref0060">https://github.com/xxy39/TRM_OV_sc</ext-link>, the proligerative and exhaustive clusters have TRM%&#x000a0;&#x0003e;&#x000a0;60% while the stemness clusters have TRM%&#x000a0;&#x0003c;&#x000a0;40%.</p></list-item><list-item id="o0440"><label>d.</label><p id="p0640">Assign groups to cells based on cell type (TRM or Recirculating) and differentiation states (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>C).</p></list-item></list></p></list-item><list-item id="o0445"><label>49.</label><p id="p0645">The following steps include the analysis of T&#x000a0;cell clonotypes, following script <ext-link ext-link-type="uri" xlink:href="https://github.com/xxy39/TRM_OV_sc/blob/main/Clonotype.R" id="intref0065">https://github.com/xxy39/TRM_OV_sc/blob/main/Clonotype.R</ext-link>.<list list-type="simple" id="olist0175"><list-item id="o0450"><label>a.</label><p id="p0650">Add V(D)J clonotypes identified by VDJ assay from the same cells to meta data of Seurat object <italic>integrated.</italic></p></list-item><list-item id="o0455"><label>b.</label><p id="p0655">Measure between-group clonotype similarity by Morisita-Horn similarity index (<xref rid="bib5" ref-type="bibr">Rempala and Seweryn, 2013</xref>) using R package <italic>fossil</italic> (<xref rid="bib8" ref-type="bibr">Vavrek, 2011</xref>). This index compares overlap between clonotypes of any two groups and ranges from 0 (no overlap) and 1 (complete overlap). The similarity index can be visualized by heatmap (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>D).</p></list-item><list-item id="o0460"><label>c.</label><p id="p0660">Plot trajectory of individual clonotypes onto UMAP projection generated by step 48 (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>E).</p></list-item></list></p></list-item><list-item id="o0465"><label>50.</label><p id="p0665">Validate the T&#x000a0;cell trajectory using ATAC assay in Multiome data. Refer the scripts at GitHub <ext-link ext-link-type="uri" xlink:href="https://github.com/xxy39/TRM_OV_sc/blob/main/ATAC.plot.R" id="intref0070">https://github.com/xxy39/TRM_OV_sc/blob/main/ATAC.plot.R</ext-link>.<list list-type="simple" id="olist0185"><list-item id="o0470"><label>a.</label><p id="p0670">Process the ATAC data generated from CellRanger-arc workflow using R package <italic>Signac</italic> (<xref rid="bib7" ref-type="bibr">Stuart et al., 2021</xref>). Merge TRM and recirculating cells from the same patient.<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> For this analysis following files generated by CellRanger-arc are required: atac_fragments.tsv.gz, atac_fragments.tsv.gz.tbi, atac_peaks.bed, per_barcode_metrics.csv.</p></disp-quote></p></list-item><list-item id="o0475"><label>b.</label><p id="p0675">Remove low-quality cells with total number of fragments in peaks&#x000a0;&#x0003c;&#x000a0;3,000 or&#x000a0;&#x0003e;&#x000a0;20,000, fraction of fragments in peaks&#x000a0;&#x0003c;&#x000a0;15%, ratio of mononucleosomal to nucleosome-free fragments&#x000a0;&#x0003e;&#x000a0;4, or transcriptional start site (TSS) enrichment score&#x000a0;&#x0003c;&#x000a0;2.<disp-quote><p><inline-graphic xlink:href="fx3.gif"/><bold>CRITICAL:</bold> These filtering criteria are dataset specific. We recommend choosing the cutoff after careful examination of the data.</p></disp-quote></p></list-item><list-item id="o0480"><label>c.</label><p id="p0680">Perform a latent semantic indexing (LSI) dimension reduction on the filtered cells.</p></list-item><list-item id="o0485"><label>d.</label><p id="p0685">Integrate merged data across patients and perform batch correction using RunHarmony() function implemented in R package <italic>harmony</italic> (<xref rid="bib3" ref-type="bibr">Korsunsky et&#x000a0;al., 2019</xref>).</p></list-item><list-item id="o0490"><label>e.</label><p id="p0690">Create a gene activity matrix by counting reads mapped to gene body and promoter regions (extended 2 kb upstream from gene coordinates) using GeneActivity() function in <italic>Signac</italic>, and further log-normalize the matrix using NormalizeData() function in <italic>Seurat</italic> with default settings.</p></list-item><list-item id="o0495"><label>f.</label><p id="p0695">Assign cells into major groups based on their grouping information obtained from Multiome GEX data following steps 42&#x02013;48.</p></list-item><list-item id="o0500"><label>g.</label><p id="p0700">Visualize the activity of T&#x000a0;cell differentiation states markers in each group (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>F). This step is to further confirm the T&#x000a0;cell trajectory using chromatin accessibility data.</p></list-item></list></p></list-item></list></p></sec></sec><sec id="sec4"><title>Expected outcomes</title><p id="p0705">This protocol is intended for isolation of CD8 TILs from ovarian tumors frozen as single cell suspension. Using dead cell removal kit and quick processing of the sample, sorting and encapsulations, viabilities around 70%&#x02013;90% can be obtained.</p><p id="p0710">ScRNAseq&#x000a0;+ scVDJseq can encapsulate 10,000 cells/ sample. TRM cells in ovarian tumors normally represent around 60% of CD8 TILs. Therefore, we reach this number easily. However, depending on the tumor size, or the frequency of your target population, this number may not be reached. Lower numbers can also be used to encapsulate and study the heterogeneity of TILS.</p><p id="p0715">This protocol also provides scripts for process single-cell RNA/TCR/ATAC-seq data from sorted TRM and recirculating CD8+ T&#x000a0;cells. Following these scripts, it is possible to integrate the multi-omic single-cell data, remove batch effects, and identify T&#x000a0;cell developmental trajectory: Recirculating&#x02192;TRMstem &#x02192; TRMeffector &#x02192; TRMproliferative &#x02192; TRMexhaustive, and generate plots as shown in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>.</p></sec><sec id="sec5"><title>Limitations</title><p id="p0720">Cell viability is extremely important. Therefore, the faster you process the sample before encapsulation, the higher the possibility to get good results. For this reason, try to process few samples at the same time, and try to encapsulate the sample as soon as the FACS sort is done. To minimize sorting time, we use Dead Cell removal Kit. However, other kits to enrich your target population could be also a good option to minimize this time.</p><p id="p0725">The number of cells that you need for encapsulation is low, but If your population has low frequency try to start with more material and use enrichment kits to reduce the sorting time.</p></sec><sec id="sec6"><title>Troubleshooting</title><sec id="sec6.1"><title>Problem 1</title><p id="p0730">The T&#x000a0;cell numbers of some samples turn out to be much less than expected (related to step 28).</p></sec><sec id="sec6.2"><title>Potential solution</title><p id="p0735">FACS cannot guarantee that all the recovered cells are T&#x000a0;cells, and may not recover all the T&#x000a0;cells effectively. The varying percentages of T&#x000a0;cells among TILs samples depend on samples sources and enrichment. Therefore, it is worthy to analyze the sample by flow cytometry to choose the best possible sample before the final sorting.</p></sec><sec id="sec6.3"><title>Problem 2</title><p id="p0740">The final recovered cell number is way off the targeted cell number (related to step 27).</p></sec><sec id="sec6.4"><title>Potential solution</title><p id="p0745">
<list list-type="simple" id="ulist0015"><list-item id="u0030"><label>&#x02022;</label><p id="p0750">The input cell concentration is not accurately counted. We strongly suggest measuring the cell concentrations on cellometer using AO/PI staining solution three times and using the average.</p></list-item><list-item id="u0035"><label>&#x02022;</label><p id="p0755">The cell concentration is either too low or too high. Our experience indicates that the cell concentration of &#x0003c;600 cells or &#x0003e;2,000 cells/ul will impact the accuracy of both concentration and the viability.</p></list-item><list-item id="u0040"><label>&#x02022;</label><p id="p0760">Cell heterogeneity impacts the accuracy of cell counting.</p></list-item><list-item id="u0045"><label>&#x02022;</label><p id="p0765">Red cell lysis is a must as the red cell will be encapsulated. Cell counting using single staining solution such as trypan and counting on hemocytometer likely overestimates the cells since the red blood cells will be included.</p></list-item><list-item id="u0050"><label>&#x02022;</label><p id="p0770">Remove the debris since debris sometime are considered as cells on some counting device. To remove small suspension particles we filter by 0.2&#x000a0;&#x003bc;m FBS used for sample collection after sorting and single cells resuspension solution.</p></list-item><list-item id="u0055"><label>&#x02022;</label><p id="p0775">Prevent cell aggregate and clump as much as possible.</p></list-item></list>
</p></sec><sec id="sec6.5"><title>Problem 3</title><p id="p0780">Sorted cell viability decreases quickly which leads to a poor data.</p></sec><sec id="sec6.6"><title>Potential solution</title><p id="p0785">
<list list-type="simple" id="ulist0020"><list-item id="u0060"><label>&#x02022;</label><p id="p0790">Minimize the sorting time as much as possible (related to step 24).</p></list-item><list-item id="u0065"><label>&#x02022;</label><p id="p0795">Process no more than 4 samples at one encapsulation (related to step 30).</p></list-item><list-item id="u0070"><label>&#x02022;</label><p id="p0800">Do multiple encapsulations if more than 4 cell samples are processed in one experiment.</p></list-item></list>
</p></sec><sec id="sec6.7"><title>Problem 4</title><p id="p0805">A large size peak exit in the Multiome library as shown in <xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref> (related to step 31):<fig id="fig4"><label>Figure&#x000a0;4</label><caption><p>Bioanalyzer run profile for DNA</p></caption><graphic xlink:href="gr4"/></fig></p></sec><sec id="sec6.8"><title>Potential solution</title><p id="p0810">The causes of the large size peak are under extensive discussion and may be due to, but not limited to multiple factors, such as low cell viability, DNA contamination, failure of RNase inhibitor, cell overlysis and inappropriate bead size selection etc., so the potential solutions can be:<list list-type="simple" id="ulist0025"><list-item id="u0075"><label>&#x02022;</label><p id="p0815">Perform the dead cell removal to remove the ambient DNA as much as possible.</p></list-item><list-item id="u0080"><label>&#x02022;</label><p id="p0820">DNase treatment of the cell suspension to remove the ambient DNA if needed, and then wash thoroughly to remove DNase.</p></list-item><list-item id="u0085"><label>&#x02022;</label><p id="p0825">Prepare fresh diluted nuclei buffer, wash buffer and lysis buffer.</p></list-item><list-item id="u0090"><label>&#x02022;</label><p id="p0830">Optimize the cell lysis time.</p></list-item><list-item id="u0095"><label>&#x02022;</label><p id="p0835">Follow exactly the protocol to perform the DNA size selection.</p></list-item><list-item id="u0100"><label>&#x02022;</label><p id="p0840">Use the verified brands of RNase inhibitors.</p></list-item></list></p></sec><sec id="sec6.9"><title>Problem 5</title><p id="p0845">Integration step of bioinformatics analysis is slow and memory consuming when dealing with large number of single-cell RNAseq samples (related to step 46).</p></sec><sec id="sec6.10"><title>Potential solution</title><p id="p0850">Use R package FastIntegartion (<xref rid="bib4" ref-type="bibr">Li et&#x000a0;al., 2022</xref>), a faster and hig-capcacity version of Seurat Integration function.</p></sec></sec><sec id="sec7"><title>Resource availability</title><sec id="sec7.1"><title>Lead contact</title><p id="p0855">Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Xiaoqing Yu (<ext-link ext-link-type="uri" xlink:href="mailto:xiaoqing.yu@moffitt.org" id="intref0075">xiaoqing.yu@moffitt.org</ext-link>).</p></sec><sec id="sec7.2"><title>Materials availability</title><p id="p0860">This study did not generate new unique reagents.</p></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Aibar</surname><given-names>S.</given-names></name><name><surname>Gonz&#x000e1;lez-Blas</surname><given-names>C.B.</given-names></name><name><surname>Moerman</surname><given-names>T.</given-names></name><name><surname>Huynh-Thu</surname><given-names>V.A.</given-names></name><name><surname>Imrichova</surname><given-names>H.</given-names></name><name><surname>Hulselmans</surname><given-names>G.</given-names></name><name><surname>Rambow</surname><given-names>F.</given-names></name><name><surname>Marine</surname><given-names>J.-C.</given-names></name><name><surname>Geurts</surname><given-names>P.</given-names></name><name><surname>Aerts</surname><given-names>J.</given-names></name><etal/></person-group><article-title>SCENIC: single-cell regulatory network inference and clustering</article-title><source>Nat. Methods</source><volume>14</volume><year>2017</year><fpage>1083</fpage><lpage>1086</lpage><pub-id pub-id-type="pmid">28991892</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Anadon</surname><given-names>C.M.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>H&#x000e4;nggi</surname><given-names>K.</given-names></name><name><surname>Biswas</surname><given-names>S.</given-names></name><name><surname>Chaurio</surname><given-names>R.A.</given-names></name><name><surname>Martin</surname><given-names>A.</given-names></name><name><surname>Payne</surname><given-names>K.K.</given-names></name><name><surname>Mandal</surname><given-names>G.</given-names></name><name><surname>Innamarato</surname><given-names>P.</given-names></name><name><surname>Harro</surname><given-names>C.M.</given-names></name><etal/></person-group><article-title>Ovarian cancer immunogenicity is governed by&#x000a0;a narrow subset of progenitor tissue-resident memory T&#x000a0;cells</article-title><source>Cancer Cell</source><volume>40</volume><year>2022</year><fpage>545</fpage><lpage>557.e513</lpage><pub-id pub-id-type="pmid">35427494</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Korsunsky</surname><given-names>I.</given-names></name><name><surname>Millard</surname><given-names>N.</given-names></name><name><surname>Fan</surname><given-names>J.</given-names></name><name><surname>Slowikowski</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Wei</surname><given-names>K.</given-names></name><name><surname>Baglaenko</surname><given-names>Y.</given-names></name><name><surname>Brenner</surname><given-names>M.</given-names></name><name><surname>Loh</surname><given-names>P.-r.</given-names></name><name><surname>Raychaudhuri</surname><given-names>S.</given-names></name></person-group><article-title>Fast, sensitive and accurate integration of single-cell data with Harmony</article-title><source>Nat. Methods</source><volume>16</volume><year>2019</year><fpage>1289</fpage><lpage>1296</lpage><pub-id pub-id-type="pmid">31740819</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Ang</surname><given-names>K.S.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group><article-title>FastIntegration: a fast and high-capacity version of Seurat Integration for large-scale integration of single-cell data</article-title><comment>Preprint at</comment><source>bioRxiv</source><year>2022</year><pub-id pub-id-type="doi">10.1101/2022.05.10.491296</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Rempala</surname><given-names>G.A.</given-names></name><name><surname>Seweryn</surname><given-names>M.</given-names></name></person-group><article-title>Methods for diversity and overlap analysis in T-cell receptor populations</article-title><source>J.&#x000a0;Math. Biol.</source><volume>67</volume><year>2013</year><fpage>1339</fpage><lpage>1368</lpage><pub-id pub-id-type="pmid">23007599</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T.</given-names></name><name><surname>Butler</surname><given-names>A.</given-names></name><name><surname>Hoffman</surname><given-names>P.</given-names></name><name><surname>Hafemeister</surname><given-names>C.</given-names></name><name><surname>Papalexi</surname><given-names>E.</given-names></name><name><surname>Mauck</surname><given-names>W.M.</given-names><suffix>III</suffix></name><name><surname>Hao</surname><given-names>Y.</given-names></name><name><surname>Stoeckius</surname><given-names>M.</given-names></name><name><surname>Smibert</surname><given-names>P.</given-names></name><name><surname>Satija</surname><given-names>R.</given-names></name></person-group><article-title>Comprehensive integration of single-cell data</article-title><source>Cell</source><volume>177</volume><year>2019</year><fpage>1888</fpage><lpage>1902.e21</lpage><pub-id pub-id-type="pmid">31178118</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T.</given-names></name><name><surname>Srivastava</surname><given-names>A.</given-names></name><name><surname>Lareau</surname><given-names>C.</given-names></name><name><surname>Satija</surname><given-names>R.</given-names></name></person-group><article-title>Multimodal single-cell chromatin analysis with Signac</article-title><source>Nature Methods</source><volume>18</volume><issue>11</issue><year>2021</year><fpage>1333</fpage><lpage>1341</lpage><pub-id pub-id-type="doi">10.1038/s41592-021-01282-5</pub-id><pub-id pub-id-type="pmid">34725479</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="opt8cNxucwi0P"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>G.</given-names></name><name><surname>Lenhard</surname><given-names>B.</given-names></name></person-group><article-title>TFBSTools: an R/Bioconductor package for transcription factor binding site analysis</article-title><source>Bioinformatics</source><volume>32</volume><year>2016</year><fpage>1555</fpage><lpage>1556</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btw024</pub-id><pub-id pub-id-type="pmid">26794315</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Vavrek</surname><given-names>M.</given-names></name></person-group><article-title>Fossil: palaeoecological and palaeogeographical analysis tools</article-title><source>Palaeontol. Electron.</source><volume>14</volume><year>2011</year><fpage>16</fpage></element-citation></ref></ref-list><sec sec-type="data-availability" id="da0010"><title>Data and code availability</title><p id="p0030">The scripts used in this protocol can be retrieved: <ext-link ext-link-type="uri" xlink:href="https://github.com/xxy39/TRM_OV_sc/" id="intref0015">https://github.com/xxy39/TRM_OV_sc/</ext-link>. The data used as example are available at Gene Expression Omnibus (GEO) under accession ID GSE195486. Description for analysis of single-cell omics data can also be found in Methods section of Anadon et&#x000a0;al. (<xref rid="bib2" ref-type="bibr">Anadon et&#x000a0;al., 2022</xref>).</p></sec><ack id="ack0010"><title>Acknowledgments</title><p id="p0870">Support for Shared Resources was provided by <funding-source id="gs1">Cancer Center Support Grant</funding-source> (CCSG) CA076292 to <funding-source id="gs2"><institution-wrap><institution-id institution-id-type="doi">10.13039/100005567</institution-id><institution>H. Lee Moffitt Cancer Center</institution></institution-wrap></funding-source> and by CCSG CA010815 to The <funding-source id="gs3"><institution-wrap><institution-id institution-id-type="doi">10.13039/100017119</institution-id><institution>Wistar Institute</institution></institution-wrap></funding-source>. We are particularly grateful to the Biostatistics and Bioinformatics, Genomics, and Flow Cytometry (an <funding-source id="gs4"><institution-wrap><institution-id institution-id-type="doi">10.13039/100017119</institution-id><institution>NCI</institution></institution-wrap></funding-source> designated Comprehensive Cancer Center, P30-CA076292) shared Facilities at Moffitt for outstanding technical support. This study was supported by R01CA157664, R01CA124515, R01CA178687, R01CA211913, and U01CA232758 to <funding-source id="gs5">J.R.C.-G</funding-source>.</p><sec id="sec9"><title>Author contributions</title><p id="p0875">C.M.A., C.Z., J.R.C.-G., and X.Y. designed and optimized protocols. C.M.A. and C.Z. performed experiments. X.Y., X.W., and L.C. performed bioinformatic analyses. J.R.C.-G. obtained fundings. All authors contributed to writing and editing the manuscript.</p></sec><sec sec-type="COI-statement" id="sec10"><title>Declaration of interests</title><p id="p0880">J.R.C.-G. has stock options in Compass Therapeutics, Anixa Biosciences, and Alloy Therapeutics; has sponsored research with Anixa Biosciences; receives honorarium from Alloy Therapeutics and Leidos; and has intellectual property with Compass Therapeutics and Anixa Biosciences.</p></sec></ack></back></article>
